Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana

Conditions:   Pre-Exposure Prophylaxis (PrEP);   Breast Feeding Intervention:   Drug: Cabotegravir Injection [Apretude] Sponsors:   Beth Israel Deaconess Medical Center;   Botswana Harvard AIDS Institute Partnership;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   ViiV Healthcare Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials